Rexahn Pharmaceuticals, Inc. (REXN)

[hopester]

Good support around these level. Would expect a small pop from here or sideways for awhile.
Fundamentals haven't changed. Still a promising drug(s). They will partner as they said; but not immediately as they are sifting and sorting several proposals from several prospects to see which is most beneficial.They indicated they'd have one by mid-year. Investors were looking for earlier agreement.
The selling "seems" to have come from the inside from options that were exercised or some derivatives , converted to stock and sold. MY TAKE ONLY! The "flipper" still holds a considerable am't of shares. Check the SEC filing under Beneficial Owners.